rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2011-5-30
|
pubmed:abstractText |
Soluble mesothelin (SM) and megakaryocyte potentiating factor (MPF) are serum biomarkers of mesothelioma. This study aims to examine the longitudinal behavior of SM and MPF in controls to gain insight in the optimal use of these biomarkers in screening.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1556-1380
|
pubmed:author |
pubmed-author:BosquéeLionelL,
pubmed-author:De VuystPaulP,
pubmed-author:DelangheJoris RJR,
pubmed-author:GermonpréPaulP,
pubmed-author:HollevoetKevinK,
pubmed-author:KishiYoshiroY,
pubmed-author:NackaertsKristiaanK,
pubmed-author:ThimpontJoëlJ,
pubmed-author:Van CleemputJorisJ,
pubmed-author:VansteelandtStijnS,
pubmed-author:van MeerbeeckJan PJP
|
pubmed:issnType |
Electronic
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
889-95
|
pubmed:dateRevised |
2011-10-26
|
pubmed:meshHeading |
pubmed-meshheading:21358346-Aged,
pubmed-meshheading:21358346-Asbestos,
pubmed-meshheading:21358346-Cohort Studies,
pubmed-meshheading:21358346-Female,
pubmed-meshheading:21358346-Follow-Up Studies,
pubmed-meshheading:21358346-GPI-Linked Proteins,
pubmed-meshheading:21358346-Glomerular Filtration Rate,
pubmed-meshheading:21358346-Humans,
pubmed-meshheading:21358346-Longitudinal Studies,
pubmed-meshheading:21358346-Male,
pubmed-meshheading:21358346-Mesothelioma,
pubmed-meshheading:21358346-Middle Aged,
pubmed-meshheading:21358346-Occupational Exposure,
pubmed-meshheading:21358346-Pleural Neoplasms,
pubmed-meshheading:21358346-Prognosis,
pubmed-meshheading:21358346-Prospective Studies,
pubmed-meshheading:21358346-Tumor Markers, Biological
|
pubmed:year |
2011
|
pubmed:articleTitle |
Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study.
|
pubmed:affiliation |
Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium. kevin.hollevoet@ugent.be
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|